170 related articles for article (PubMed ID: 22099707)
1. Circulating tissue factor positive microparticles in patients with acute recurrent deep venous thrombosis.
Ye R; Ye C; Huang Y; Liu L; Wang S
Thromb Res; 2012 Aug; 130(2):253-8. PubMed ID: 22099707
[TBL] [Abstract][Full Text] [Related]
2. Microparticle-associated tissue factor activity in patients with acute unprovoked deep vein thrombosis and during the course of one year.
Thaler J; Koppensteiner R; Pabinger I; Ay C; Gremmel T
Thromb Res; 2014 Nov; 134(5):1093-6. PubMed ID: 25262106
[TBL] [Abstract][Full Text] [Related]
3. Monocytes and plasma tissue factor levels in normal individuals and patients with deep venous thrombosis of the lower limbs: potential diagnostic tools?
Vieira LM; Dusse LM; Fernandes AP; Martins-Filho OA; de Bastos M; Ferreira MF; Cooper AJ; Lwaleed BA; Carvalho MG
Thromb Res; 2007; 119(2):157-65. PubMed ID: 16527335
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
5. Microvesicles as risk markers for venous thrombosis.
Rautou PE; Mackman N
Expert Rev Hematol; 2013 Feb; 6(1):91-101. PubMed ID: 23373784
[TBL] [Abstract][Full Text] [Related]
6. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
[TBL] [Abstract][Full Text] [Related]
7. Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb.
Gremmel T; Ay C; Seidinger D; Pabinger I; Panzer S; Koppensteiner R
J Vasc Surg; 2011 Dec; 54(6 Suppl):48S-55S. PubMed ID: 21890302
[TBL] [Abstract][Full Text] [Related]
8. Circulating tissue factor and microparticles are not increased in patients with deep vein thrombosis.
Steppich BA; Hassenpflug M; Braun SL; Schömig K; von Beckerath O; von Beckerath N; Eckstein HH; Ott I
Vasa; 2011 Mar; 40(2):117-22. PubMed ID: 21500176
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice.
Thomas GM; Brill A; Mezouar S; Crescence L; Gallant M; Dubois C; Wagner DD
J Thromb Haemost; 2015 Jul; 13(7):1310-9. PubMed ID: 25955268
[TBL] [Abstract][Full Text] [Related]
10. Circulating microparticles in patients with antiphospholipid antibodies: characterization and associations.
Chaturvedi S; Cockrell E; Espinola R; Hsi L; Fulton S; Khan M; Li L; Fonseca F; Kundu S; McCrae KR
Thromb Res; 2015 Jan; 135(1):102-8. PubMed ID: 25467081
[TBL] [Abstract][Full Text] [Related]
11. Combined D-dimer and clinical probability are useful for exclusion of recurrent deep venous thrombosis.
Aguilar C; del Villar V
Am J Hematol; 2007 Jan; 82(1):41-4. PubMed ID: 16947316
[TBL] [Abstract][Full Text] [Related]
12. Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism.
Kamikura Y; Wada H; Nobori T; Kobayashi T; Sase T; Nishikawa M; Ishikura K; Yamada N; Abe Y; Nishioka J; Nakano T; Shiku H
Thromb Res; 2005; 116(4):307-12. PubMed ID: 16038715
[TBL] [Abstract][Full Text] [Related]
13. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
[TBL] [Abstract][Full Text] [Related]
14. Circulating microparticles in carriers of factor V Leiden with and without a history of venous thrombosis.
Campello E; Spiezia L; Radu CM; Bon M; Gavasso S; Zerbinati P; Woodhams B; Tormene D; Prandoni P; Simioni P
Thromb Haemost; 2012 Oct; 108(4):633-9. PubMed ID: 22836806
[TBL] [Abstract][Full Text] [Related]
15. Circulating procoagulant microparticles in cancer patients.
Thaler J; Ay C; Weinstabl H; Dunkler D; Simanek R; Vormittag R; Freyssinet JM; Zielinski C; Pabinger I
Ann Hematol; 2011 Apr; 90(4):447-53. PubMed ID: 20981426
[TBL] [Abstract][Full Text] [Related]
16. Platelet factor 4 and β-thromboglobulin mRNAs in circulating microparticles of trauma patients as diagnostic markers for deep vein thrombosis.
Su Y; Chen Y; Zhang W; Liu L; Cao X; Wu J
J Thromb Thrombolysis; 2020 Oct; 50(3):525-532. PubMed ID: 32347511
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism.
Garcia Rodriguez P; Eikenboom HC; Tesselaar ME; Huisman MV; Nijkeuter M; Osanto S; Bertina RM
Thromb Res; 2010 Oct; 126(4):345-9. PubMed ID: 20708219
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of a screening protocol to exclude deep vein thrombosis on the basis of a combination of quantitative D-dimer testing and pretest clinical probability score.
Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
J Am Coll Surg; 2005 Nov; 201(5):701-9. PubMed ID: 16256912
[TBL] [Abstract][Full Text] [Related]
19. Markers of plasma coagulation and fibrinolysis after acute deep venous thrombosis.
Meissner MH; Zierler BK; Bergelin RO; Chandler WC; Manzo RA; Strandness DE
J Vasc Surg; 2000 Nov; 32(5):870-80. PubMed ID: 11054218
[TBL] [Abstract][Full Text] [Related]
20. Circulating microparticles of glial origin and tissue factor bearing in high-grade glioma: a potential prothrombotic role.
Sartori MT; Della Puppa A; Ballin A; Campello E; Radu CM; Saggiorato G; d'Avella D; Scienza R; Cella G; Simioni P
Thromb Haemost; 2013 Aug; 110(2):378-85. PubMed ID: 23803674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
